Andrew Astor - Dec 14, 2021 Form 4 Insider Report for NEPHROS INC (NEPH)

Role: President & CEO, Director
Signature: /s/ Christopher Melsha as attorney-in-fact for Andrew Astor pursuant to Power of Attorney previously filed.
Stock symbol: NEPH
Transactions as of: Dec 14, 2021
Transactions value $: $0
Form type: 4
Date filed: 12/16/2021, 08:16 PM
Previous filing: Aug 18, 2021
Next filing: Mar 7, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NEPH	Common Stock						78K	Dec 14, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NEPH	Stock Option (right to buy)	Award	$0	+38.6K		$0.00	38.6K	Dec 14, 2021	Common Stock	38.6K	$6.82	Direct	F7
holding	NEPH	Warrants (right to buy)						14.8K	Dec 14, 2021	Common Stock	14.8K	$2.70	Direct
holding	NEPH	Stock Option (right to buy)						64.4K	Dec 14, 2021	Common Stock	64.4K	$4.14	Direct	F1
holding	NEPH	Stock Option (right to buy)						46.5K	Dec 14, 2021	Common Stock	46.5K	$2.64	Direct	F2
holding	NEPH	Stock Option (right to buy)						5.56K	Dec 14, 2021	Common Stock	5.56K	$4.50	Direct	F3
holding	NEPH	Stock Option (right to buy)						22.2K	Dec 14, 2021	Common Stock	22.2K	$5.85	Direct	F4
holding	NEPH	Stock Option (right to buy)						20K	Dec 14, 2021	Common Stock	20K	$8.30	Direct	F5
holding	NEPH	Stock Option (right to buy)						152K	Dec 14, 2021	Common Stock	152K	$7.07	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On 2/13/17, the Reporting Person was granted an option to purchase 64,399 shares of common stock of the Company. Options to purchase 8,049 shares vested on 2/13/18; options to purchase 24,150 shares vest quarterly in 12 equal amounts commencing on 5/13/18; and options to purchase 32,200 shares vested upon achievement of previously disclosed performance measures.
F2	On 5/1/17, the Reporting Person was granted an option to purchase 46,525 shares of common stock of the Company. Options to purchase 5,815 shares vested on 5/1/18; options to purchase 17,447 shares vest quarterly in 12 equal amounts commencing on 7/1/18; and options to purchase 23,263 shares vested upon achievement of previously disclosed performance measures.
F3	On 12/20/17, the Reporting Person was granted an option to purchase 5,556 shares of common stock of the Company. Options to purchase 1,389 shares vested on 12/20/18 and options to purchase 4,167 shares vest quarterly in 12 equal amounts commencing on 3/20/19.
F4	On 12/19/18, the Reporting Person was granted an option to purchase 22,223 shares of common stock of the Company. Options to purchase 5,555 shares vested on 12/19/19 and options to purchase 16,668 shares vest quarterly in 12 equal amounts commencing on 3/19/20.
F5	On 12/16/19, the Reporting Person was granted an option to purchase 20,000 shares of common stock of the Company. Options to purchase 5,000 shares vest on 12/16/20 and options to purchase 15,000 shares vest quarterly in 12 equal amounts commencing on 3/16/21.
F6	On 8/24/20, the Reporting Person was granted an option to purchase 152,064 shares of common stock of the Company. Options to purchase 38,016 shares vest on 8/24/21 and options to purchase 114,048 shares vest quarterly in 12 equal amounts commencing on 11/24/21.
F7	On 12/14/21, the Reporting Person was granted an option to purchase 38,612 shares of common stock of the Company. Options to purchase 9,653 shares vest on 12/14/22 and options to purchase 28,959 shares vest quarterly in 12 equal amounts commencing on 3/14/23.